Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

April 01, 2016; Volume 357,Issue 1

Minireviews

  • You have access
    The Pharmacological Basis of Cannabis Therapy for Epilepsy
    Doodipala Samba Reddy and Victoria M. Golub
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 45-55; DOI: https://doi.org/10.1124/jpet.115.230151
  • You have access
    Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics
    Casey O. Ligon, Rachel D. Moloney and Beverley Greenwood-Van Meerveld
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 84-93; DOI: https://doi.org/10.1124/jpet.115.231670

Behavioral Pharmacology

  • You have access
    Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys
    Phillip A. Saccone, Kathy A. Zelenock, Angela M. Lindsey, Agnieszka Sulima, Kenner C. Rice, Eric P. Prinssen, Jürgen Wichmann and James H. Woods
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 17-23; DOI: https://doi.org/10.1124/jpet.115.231134
  • You have access
    Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates
    Brian D. Kangas, Michael Z. Leonard, Vidyanand G. Shukla, Shakiru O. Alapafuja, Spyros P. Nikas, Alexandros Makriyannis and Jack Bergman
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 125-133; DOI: https://doi.org/10.1124/jpet.115.228189
  • You have access
    The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model
    Jenny L. Wilkerson, Micah J. Niphakis, Travis W. Grim, Mohammed A. Mustafa, Rehab A. Abdullah, Justin L. Poklis, William L. Dewey, Hamid Akbarali, Matthew L. Banks, Laura E. Wise, Benjamin F. Cravatt and Aron H. Lichtman
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 145-156; DOI: https://doi.org/10.1124/jpet.115.229971

Cardiovascular

  • You have access
    Inhibition of KV7 Channels Protects the Rat Heart against Myocardial Ischemia and Reperfusion Injury
    Elise R. Hedegaard, Jacob Johnsen, Jonas A. Povlsen, Nichlas R. Jespersen, Jeffrey A. Shanmuganathan, Mia R. Laursen, Steen B. Kristiansen, Ulf Simonsen and Hans Erik Bøtker
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 94-102; DOI: https://doi.org/10.1124/jpet.115.230409

Cellular and Molecular

  • You have access
    Ethanol Regulation of Synaptic GABAA α4 Receptors Is Prevented by Protein Kinase A Activation
    Stephen L. Carlson, John Peyton Bohnsack and A. Leslie Morrow
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 10-16; DOI: https://doi.org/10.1124/jpet.115.230417
  • You have access
    Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation
    Elizabeth A. Vecchio, Christina Y. R. Tan, Karen J. Gregory, Arthur Christopoulos, Paul J. White and Lauren T. May
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 36-44; DOI: https://doi.org/10.1124/jpet.115.230003

Drug Discovery and Translational Medicine

  • You have access
    5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists
    Jennifer L. Harmon, Lauren P. Wills, Caitlin E. McOmish, Elena Y. Demireva, Jay A. Gingrich, Craig C. Beeson and Rick G. Schnellmann
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 1-9; DOI: https://doi.org/10.1124/jpet.115.228395
  • You have access
    Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine
    Aaron Janowsky, Dilip K. Tosh, Amy J. Eshleman and Kenneth A. Jacobson
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 24-35; DOI: https://doi.org/10.1124/jpet.115.229666
  • You have access
    Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone
    Sung Oh Ahn, Shuichi Ohtomo, Jumpei Kiyokawa, Toshito Nakagawa, Mizuki Yamane, Kyoung June Lee, Ki Hwan Kim, Byung Ho Kim, Jo Tanaka, Yoshiki Kawabe and Naoshi Horiba
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 157-166; DOI: https://doi.org/10.1124/jpet.115.231647
  • You have access
    3,3′-Diindolylmethane Ameliorates Staphylococcal Enterotoxin B–Induced Acute Lung Injury through Alterations in the Expression of MicroRNA that Target Apoptosis and Cell-Cycle Arrest in Activated T Cells
    David M. Elliott, Mitzi Nagarkatti and Prakash S. Nagarkatti
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 177-187; DOI: https://doi.org/10.1124/jpet.115.226563

Endocrine and Diabetes

  • You have access
    Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas
    Ryo Ito, Yoshiyuki Tsujihata, Masami Suzuki, Kazumasa Miyawaki, Kae Matsuda and Koji Takeuchi
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 217-227; DOI: https://doi.org/10.1124/jpet.115.230730

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • Open Access
    Ozone-Induced Hypertussive Responses in Rabbits and Guinea Pigs
    Emlyn Clay, Riccardo Patacchini, Marcello Trevisani, Delia Preti, Maria Pia Branà, Domenico Spina and Clive Page
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 73-83; DOI: https://doi.org/10.1124/jpet.115.230227

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection
    Gopinath Kasetty, Praveen Papareddy, Ravi K.V. Bhongir and Arne Egesten
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 66-72; DOI: https://doi.org/10.1124/jpet.115.229641
  • You have access
    Involvement of Extracellular Signal-Regulated Kinase 5 in Kinin B1 Receptor Upregulation in Isolated Human Umbilical Veins
    Yael Kilstein, Wanda Nowak, Andrea Emilse Errasti, Antía Andrea Barcia Feás, Arnaldo Raúl Armesto, Facundo Germán Pelorosso and Rodolfo Pedro Rothlin
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 114-124; DOI: https://doi.org/10.1124/jpet.115.230169

Metabolism, Transport, and Pharmacogenomics

  • Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter
    You have access
    Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter
    Kristin M. Bircsak, Vivek Gupta, Poi Yu Sofia Yuen, Ludwik Gorczyca, Barry I. Weinberger, Anna M. Vetrano and Lauren M. Aleksunes
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 103-113; DOI: https://doi.org/10.1124/jpet.115.230185

Neuropharmacology

  • You have access
    Cyclin-Dependent Kinase Inhibitor 1a (p21) Modulates Response to Cocaine and Motivated Behaviors
    Natalie E. Scholpa, Sherri B. Briggs, John J. Wagner and Brian S. Cummings
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 56-65; DOI: https://doi.org/10.1124/jpet.115.230888
  • You have access
    In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1
    Linda D. Simmler, Danièle Buchy, Sylvie Chaboz, Marius C. Hoener and Matthias E. Liechti
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 134-144; DOI: https://doi.org/10.1124/jpet.115.229765
  • You have access
    Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic δGABAA Receptors
    Chase Matthew Carver and Doodipala Samba Reddy
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 188-204; DOI: https://doi.org/10.1124/jpet.115.229302
  • Systems Pharmacology Analysis of the Amyloid Cascade after <em>β</em>-Secretase Inhibition Enables the Identification of an A<em>β</em>42 Oligomer Pool
    You have access
    Systems Pharmacology Analysis of the Amyloid Cascade after β-Secretase Inhibition Enables the Identification of an Aβ42 Oligomer Pool
    Eline M.T. van Maanen, Tamara J. van Steeg, Maria S. Michener, Mary J. Savage, Matthew E. Kennedy, Huub Jan Kleijn, Julie A. Stone and Meindert Danhof
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 205-216; DOI: https://doi.org/10.1124/jpet.115.230565

Toxicology

  • You have access
    Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity
    Renato J. Scialis and José E. Manautou
    Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 167-176; DOI: https://doi.org/10.1124/jpet.115.230755
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 357 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 357, Issue 1
1 Apr 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireviews
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Drug Discovery and Translational Medicine
  • Endocrine and Diabetes
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Toxicology
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics